It is already known that mirabegron can increase blood pressure. Cases of severe hypertension have been reported including hypertensive crisis associated with reports of cerebrovascular and cardiac events (mainly transient ischaemia attack or stroke).
Astellas has issued a letter containing the new recommendations for the use of mirabegron.